Boston, MA -- (SBWire) -- 09/27/2018 --Browse 43 market data Tables and 87 Figures spread over 253 Pages along with in-depth analysis on "Epigenomics market by Product (Reagents, Kits, Instruments, Enzymes, Services), by Technology (DNA Methylation, Histone Methylation & Acetylation, microRNA Modification), by Application (Oncology (DNA Methyltransferase Inhibitors, Histone Deacetylase Inhibitors), Non-oncology) by Application Area (Diagnosis, Drug Discovery, Therapy Optimization, Prognosis) by Segment (Epigenetic Diagnosis (Cancer, Neuro, Cardiovascular, Inflammatory & Autoimmune Disease, R&d, Personalized Medicine) by Geography.
This insightful market research report by Inkwood Research focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. The report covers all the aspects of this comprehensive market, by assessing major geographies such as North America, Europe, Asia Pacific, and Rest of World, and is a valuable asset for the existing players, new entrants, and future investors. The study presents a detailed market analysis, with inputs derived from industry professionals across the value chain.
Epigenomics market scenario
The advancement in prevalence of cancer and other chronic diseases, rise in the aging population, decline in the sequencing costs and time, escalation in funding for research & development, need for better cancer therapies, growth in personalized medicine & increasing importance of epigenetic technology are the factors proliferating the global epigenomics market across the globe.
The Global Epigenomics market report provides data tables and includes charts and graphs for visual analysis.
Request Free Sample Report for Epigenomics market by product, technology, application, application area, segment & Geography: https://www.inkwoodresearch.com/reports/global-epigenomics-market-forecast-2018-2026/#request-free-sample
Market Segmentation
On the basis of product, epigenomics market is segmented into:
- Reagents
- Kits
- Instruments
- Enzymes
- Services
On the basis of technology, Epigenomics market is segmented into:
- DNA Methylation
- Histone Methylation & Acetylation
- microRNA Modification
On the basis of application, epigenomics market is segmented into:
- Oncology
- Non-Oncology
On the basis of application area, epigenomics market is segmented into:
- Diagnosis
- Drug Discovery
- Therapy Optimization
- Prognosis
On the basis of segment, epigenomics market is segmented into:
- Epigenetic Diagnosis
Report Highlights
- The report provides a detailed analysis of the current and future market trends, to identify the investment opportunities
- Market forecasts till 2026, using estimated market values as the base numbers
- Key market trends across the business segments, regions and countries
- Key developments and strategies observed in the market
- Market dynamics such as drivers, restraints, opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2026
Companies Profiled
- ABBOTT LABORATORIES
- AFFYMETRIX
- AGILENT TECHNOLOGIES
- ASTELLAS PHARMACEUTICALS
- BAYER AG
- BIO VISION
- CELGENE CORP.
- EPIGENOMICS AG
- EPIGENTEK
- GLAXOSMITHKLINE
- ILLUMINA INC.
- JOHNSON & JOHNSON
- LABORATORY CORP. OF AMERICA HOLDINGS
- MERCK SHARP & DOHME
- NATUREWISE BIOTECH & MEDICALS CORP.
- NOVARTIS PHARMA AG
- ORCHID CHEMICALS & PHARMACEUTICALS LIMITED
- TBG DIAGNOSTICS LIMITED
- RUBICON GENOMICS
- ROCHE HOLDING AG
Related Reports
Medical Lighting Technologies market- The global medical lighting technologies market is anticipated to grow at a CAGR of 5.74% during the years 2018-2026.
Cell-free DNA (cfDNA) Testing market- The global cell-free DNA (cfDNA) testing market is anticipated to grow at a CAGR of 18.52% in terms of units and 16.46% in terms of revenue between 2018-2026.
Gynecology Devices market- The global gynecology devices market is anticipated to grow at a CAGR of 8.42% during the forecasting years 2018 to 2026.
Metastatic Cancer Treatment Market- The global metastatic cancer treatment market is anticipated to grow at a CAGR of 7.13% between 2018 to 2026.
3D Medical Imaging market- The global 3D medical imaging market is anticipated to grow at a CAGR of 9.03% during the years 2018-2026.
